Yulin First People's Hospital
Welcome,         Profile    Billing    Logout  
 29 Trials 
44 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Ping
NCT06381323: The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Recruiting
4
55
RoW
Finerenone, Nifedipine
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Primary Aldosteronism, Finerenone, Mineralocorticoid Receptor Antagonist
03/27
04/27
NCT06256289: Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Not yet recruiting
4
50
NA
Canagliflozin 100mg Tab, Invokana, Metformin Hydrochloride, Glucophage
Ping Li,MD
Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease
04/25
04/25
NCT04939441: Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)

Active, not recruiting
4
100
RoW
Tenofovir alafenamide, Vemlidy®
Jidong Jia, Beijing Ditan Hospital, ShuGuang Hospital, Tianjin Third Central Hospital, Huashan Hospital, The Sixth Peoples Hospital of Zhengzhou, Tianjin Second People's Hospital, Ruijin Hospital, Shanghai East Hospital
Chronic Hepatitis B
05/24
05/25
NCT05814770: Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Not yet recruiting
4
96
NA
Finerenone, Kerendia, Spironolactone
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, National Key Research and Development Program of China, National Natural Science Foundation of China
Primary Aldosteronism, Hypertension
03/25
03/26
NDKD, NCT06110130: Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With

Recruiting
4
60
US
Empagliflozin 10 MG, Placebo
Washington D.C. Veterans Affairs Medical Center, Boehringer Ingelheim
Chronic Kidney Diseases
12/25
12/26
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients

Recruiting
4
5000
RoW
Peginterferon Alfa-2B, Nucleoside Analogs
Third Affiliated Hospital, Sun Yat-Sen University
Hepatitis B, Chronic
12/26
11/29
NCT04373967: Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes

Recruiting
3
424
RoW
Victoza®., Metformin Hydrochloride, TQZ2451
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Type 2 Diabetes
12/21
12/21
RECAM, NCT04807348: Chiglitazar Added to Metformin for Type 2 Diabetes

Completed
3
533
RoW
Chiglitazar 32mg, Bilessglu, CS038, Chiglitazar 48mg, Placebo, Chiglitazar simulator, Metformin Hydrochloride, Glucophage
Chipscreen Biosciences, Ltd.
Type 2 Diabetes
02/23
02/23
NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting
3
430
RoW
Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid
Eli Lilly and Company
Atopic Dermatitis
12/25
11/26
TRAPP, NCT05811676: Tranexamic Acid for the Prevention of Postpartum Hemorrhage in Pregnant Women with Placenta Previa

Recruiting
3
1680
RoW
Tranexamic acid, 0.9% sodium chloride
Guangzhou Medical University, Dongguan Maternal and Child Health Care Hospital, Foshan Women and Children Hospital, BoAi Hospital of Zhongshan, Women and Children's Hospital of Chongqing Medical University, Tianjin Central Hospital of Gynecology Obstetrics, Shandong Provincial Maternal and Child Health Care Hospital Affiliated to Qingdao University, Jinan, Urumqi Maternal and Child Health Care Hospital, Zhuhai Women and Children's Hospital, The First Affiliated Hospital of Zhengzhou University, Hunan Provincial Maternal and Child Health Care Hospital, Dalian women and children's medical group, Nanfang Hospital, Southern Medical University, Huadu District People's Hospital of Guangzhou, Northwest Women's and Children's Hospital, Xi'an, Shaanxi, First Affiliated Hospital, Sun Yat-Sen University, Shenzhen Maternity & Child Healthcare Hospital, Shenzhen Baoan Women's and Children's Hospital, Dongguan People's Hospital, First Affiliated Hospital of Xinjiang Medical University, Tongji Hospital, Peking Union Medical College, Peking University First Hospital, The First Affiliated Hospital of Guangzhou Medical University, Second Affiliated Hospital of Guangzhou Medical University, Fifth Affiliated Hospital of Guangzhou Medical University, Shijiazhuang Obstetrics and Gynecology Hospital
Hemorrhage, Postpartum, Placenta Previa
02/25
04/25
NCT06631170: Efficacy and Safety of Roflumilast Cream in Subjects with Atopic Dermatitis

Recruiting
3
351
RoW
Roflumilast Cream 0.15%, Vehicle cream
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Atopic Dermatitis (AD)
08/25
08/25
ACHIEVE, NCT04808752: Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases

Active, not recruiting
2
63
RoW
Almonertinib, Investigational Product
Zhejiang Cancer Hospital, Jiangsu Hansoh Pharmaceutical Co., Ltd.
Lung Cancer
06/24
07/24
NCT06677879: A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer.

Recruiting
2
780
RoW
Proton radiotherapy, Photon radiotherapy
Shanghai Proton and Heavy Ion Center
Breast Cancer
07/26
07/28
TQB3702-II-02, NCT06566586: A Clinical Study to Evaluate the Efficacy and Safety of TQB3702 Tablets Combined With Immunochemotherapy for the Treatment of B-cell Lymphoma

Recruiting
2
80
RoW
TQB3702 tablets+Chemotherapy regimen
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
B-cell Lymphoma
03/26
12/27
SPHIC-TR-PCa2021-01, NCT05106699: Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases

Recruiting
2
54
RoW
proton plus carbon ion radiation
Shanghai Proton and Heavy Ion Center
Prostate Cancer
05/25
05/26
SPHIC-TR-PCa2020-01, NCT05010343: Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Recruiting
2
140
RoW
carbon ion irradation, Carbon Ion Irradiation With SIB
Shanghai Proton and Heavy Ion Center
Localized Prostate Cancer
07/25
07/28
PALIZADE, NCT05781750: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis

Suspended
2
279
Europe, US, RoW
zetomipzomib, KZR-616, placebo, matching placebo
Kezar Life Sciences, Inc.
Lupus Nephritis
05/26
07/26
SPHIC-TR-BCa2022-02, NCT05692674: A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

Recruiting
2
67
RoW
adjuvant hypofractionated intensity-modulated proton radiotherapy
Shanghai Proton and Heavy Ion Center
Breast Cancer
09/28
09/28
PM8002-A001, NCT05918445: PM8002 in the Treatment of Patients With Advanced Solid Tumors

Recruiting
1/2
380
RoW
PM8002
Biotheus Inc.
Malignant Neoplasm
11/25
11/25
SPHIC-TR-PCa2019-01, NCT04724577: 12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer

Recruiting
1
30
RoW
carbon ion radiotherapy
Shanghai Proton and Heavy Ion Center
Radiotherapy, Prostate Cancer
12/22
06/23
NCT06375161: Anti-CD19-CAR-T Cells in Relapsed/Refractory B-cell Tumor Patients.

Recruiting
1
12
RoW
anti-CD19-CAR-T cells
Shanghai Tongji Hospital, Tongji University School of Medicine
B Cell Malignancies
12/25
12/39
NCT04606433: Phase I Clinical Study of GNC-038 in Patients With Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

Recruiting
1
41
RoW
GNC-038
Sichuan Baili Pharmaceutical Co., Ltd., SystImmune Inc.
Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia
06/25
11/25
TQB2223-I-01, NCT05894421: TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers

Recruiting
1
92
RoW
TQB2223 injection+ Penpulimab Injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Advanced Cancer
01/25
01/26
NCT05924750: A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Recruiting
1
26
RoW
BL-M11D1
Sichuan Baili Pharmaceutical Co., Ltd.
Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
08/25
08/25
SPHIC-TR-BCa2022-01, NCT05692661: A Dose Escalation Study of Proton and Carbon Ion Irradiation for HER2 Positive and Triple Negative Breast Cancer

Recruiting
1
24
RoW
proton plus carbon ion radiotherapy
Shanghai Proton and Heavy Ion Center
Triple Negative Breast Cancer, HER2-positive Breast Cancer
10/25
01/26
CHESS1901, NCT03990753: Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (/APPHA1901)

Recruiting
N/A
1000
RoW
esophagogastroduodenoscopy
Nanfang Hospital of Southern Medical University, Southern Medical University, China, LanZhou University, Zhongda Hospital, Medical School, Southeast University, Guangdong Second Provincial General Hospital, Xingtai People's Hospital, The Third Hospital of Zhenjiang Affiliated Jiangsu University, Tianjin Second People's Hospital, Zhejiang University Lishui Hospital, The Second Hospital of Anhui Medical University, The Sixth People's Hospital of Shenyang, Xi'an Gaoxin Hospital, King Chulalongkorn Memorial Hospital affiliated to Chulalongkorn University, Ankara University
Compensated Cirrhosis
06/21
06/22
ETRAS-China, NCT03080519: Endovascular Therapy for Renal Artery Stenosis in China

Not yet recruiting
N/A
5000
RoW
Endovascular Therapy
Chinese Academy of Medical Sciences, Fuwai Hospital
Renal Artery Obstruction, Hypertension, Renovascular
04/22
04/24
NCT04108169: Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting.

Recruiting
N/A
240
RoW
Left atrial appendage occlusion surgery
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Heart Surgery
10/22
01/23
NCT02739659: Carbon Ion Radiotherapy for the Treatment of Localized Prostate Cancer

Recruiting
N/A
73
RoW
carbon-ion radiotherapy
Shanghai Proton and Heavy Ion Center
Prostate Carcinoma
12/22
12/24
NCT05392712: Magnetocardiography in the Accurate Identification of Severe Coronary Lesions and Myocardial Necrosis

Recruiting
N/A
430
RoW
Magnetometer
Qilu Hospital of Shandong University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Weifang People's Hospital, Linyi People's Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Chongqing Emergency Medical Center, Guangdong Provincial Hospital of Traditional Chinese Medicine, First People's Hospital of Hangzhou, Central hospital Affiliated to Shandong First Medical University, Weihai Central Hospital, Heze Municipal Hospital
Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
08/24
12/24
NCT06142175: Relmacabtagene Autoleucel in Patients With LBCL

Recruiting
N/A
200
RoW
Relmacabtagene Autoleucel, JWCAR029
Shanghai Ming Ju Biotechnology Co., Ltd.
Large B-cell Lymphoma
12/24
12/24
ASORPWICE, NCT03521739: Association of Synchronous Four-limb blOod pRessure and Pulse Wave velocIty With Cardiovascular Events

Recruiting
N/A
100000
RoW
Chinese Academy of Medical Sciences, Fuwai Hospital
Blood Pressure, Pulse Wave Analysis, Ankle Brachial Index, Patient Outcome Assessment
12/22
12/23
NCT04833192: Evaluation of New Diagnostic Indicator of Subclinical Hypercortisolism

Recruiting
N/A
202
RoW
experimental group
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Adrenal Incidentaloma, Subclinical Hypercortisolism
04/23
12/23
NCT05826080: Effect of Adrenocorticotropic Hormone Stimulation During Adrenal Vein Sampling in Primary Aldosteronism

Recruiting
N/A
59
RoW
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Primary Aldosteronism, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism
10/23
09/24
NCT05896826: Magnetocardiography in the Accurate Identification of Myocardial Infarction

Recruiting
N/A
500
RoW
Magnetometer
Qilu Hospital of Shandong University, Chongqing Emergency Medical Center, Weifang People's Hospital, Linyi People's Hospital, Weihai Central Hospital, Jining First People's Hospital, The First Affiliated Hospital with Nanjing Medical University, Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital Xi'an Jiaotong University, Guangdong Provincial Hospital of Traditional Chinese Medicine, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Central hospital Affiliated to Shandong First Medical University, Heze Municipal Hospital, First People's Hospital of Hangzhou
Chest Pain, Acute Coronary Syndrome, Myocardial Infarction
10/24
12/24
NCT05021406: Extension Study of Carvedilol RCT Study

Recruiting
N/A
240
RoW
Carvedilol 12.5 MG, Nucleos(t)ide Analogues
Beijing Friendship Hospital
Liver Cirrhosis, Portal Hypertension
10/24
10/24
TAILOR-TAVR, NCT05511792: Down Sizing Strategy (HANGZHOU Solution) vs Standard Sizing Strategy TAVR in Bicuspid Aortic Stenosis (Type 0)

Recruiting
N/A
206
RoW
TAVR for BAV Using Down Sizing with the Evolut Pro platform, Down Sizing Strategy, TAVR for BAV Using Traditional Sizing strategy with the Evolut Pro platform, Standard Sizing Strategy
Second Affiliated Hospital, School of Medicine, Zhejiang University
Aortic Stenosis With Bicuspid Valve
06/25
06/29
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System

Not yet recruiting
N/A
2150
RoW
Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy
Lepu Medical Technology (Beijing) Co., Ltd.
Coronary Heart Disease
01/26
01/28
NCT03261934: Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation

Recruiting
N/A
2000
RoW
No intervention
Beijing University of Chinese Medicine, The University of Science and Technology of China, China Academy of Chinese Medical Sciences, Harvard Medical School (HMS and HSDM)
Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation
12/30
12/30
ACTRN12622000019707: Effects of recorded maternal voice on heart rate and anthropometric parameters in premature infants: A randomized controlled trial

Completed
N/A
108
 
Ping Li, Ping Li
heart rate, anthropometric parameters
 
 
NCT04289701: Hypertension Registry of "Hypertension Prevention and Control Initiative in China"

Recruiting
N/A
200000
RoW
Health Services for Systematic Hypertension Management
Chinese Academy of Medical Sciences, Fuwai Hospital
Hypertension
12/22
12/24
NCT05357456: Performances on Cognitive Functions and Brain Function and Follow-up After Different Treatments in Patients With Autonomous Cortisol Secretion: a Single-center, Prospective, Observational Study

Recruiting
N/A
62
RoW
Cognitive function assessment; functional magnetic resonance imaging, fMRI, laparoscopic adrenal surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Autonomous Cortisol Secretion, Adrenal Incidentaloma, Non-functioning Adrenal Adenomas
10/24
10/26
Yi, Haizhen
NCT06300177: D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure

Recruiting
3
522
RoW
D-1553 Tablet, Docetaxel injection
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Non Small Cell Lung Cancer
10/26
12/27
Lin, Yanni
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke

Recruiting
3
1380
RoW
Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin
Beijing Tiantan Hospital
Ischemic Stroke, Acute
12/25
12/26

Download Options